Skip to content
SEED Therapeutics logo — Pioneering the science of improving human health

SEED Therapeutics

Pioneering the science of improving human health

Founded 2019 United States New York, United States 25 employees Series A Total: $65.40M Biotechnology, Health and Wellness +1

General Information

Company Name SEED Therapeutics
Founded Year 2019
Location United States New York, United States
Employees 25
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with SEED Therapeutics. To contact SEED Therapeutics, visit seedtherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SEED Therapeutics compare?

A PDF of SEED Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SEED Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SEED Therapeutics

Seed Therapeutics is a biotechnology company founded in 2019 with a focus on improving human health through the creation of "molecular glues." These innovative therapeutics aim to degrade disease-causing proteins that were previously considered "undruggable." The company collaborates with renowned academic experts and industry professionals to develop a pipeline of potential drug candidates. In August 2024, Seed Therapeutics secured a significant $24.00M Series A investment from Eisai, signaling confidence in the company's approach to addressing severe diseases with limited treatment options. Seed Therapeutics' mission is centered around positively impacting human health by advancing novel protein degradation therapeutics in the biotechnology and health and wellness sectors.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $6.00M -
01 Aug 2025
Secondary Market $35.40M -
01 Jan 2025
Series A $24.00M 1
Eisai
01 Aug 2024
Spinout Undisclosed 2
University of Washington, New York University Grossman School of Medicine
01 Jan 2019

SEED Therapeutics Alternatives & Competitors

View All Alternatives
SEED Therapeutics vs

Clinical-stage biotech company transforming how disease is treated through targeted protein degradat...

IPO
111 employees
Biotechnology, Health Care
SEED Therapeutics vs
Cullgen Inc.
Cullgen Inc. United States

Powering protein degradation for tomorrow's medicines

Acquired
27 employees
Biotechnology, Pharmaceutical
SEED Therapeutics vs
Orum Therapeutics
Orum Therapeutics United States

A public biotechnology company pioneering a novel class of protein degraders.

IPO
55 employees
Biotechnology, Health Care

FAQ About SEED Therapeutics

Pioneering the science of improving human health
SEED Therapeutics was founded in 2019.
SEED Therapeutics is headquartered in New York, United States.
SEED Therapeutics operates in Biotechnology, Health and Wellness and Pharmaceutical.
SEED Therapeutics has approximately 25 employees.
SEED Therapeutics has completed 4 funding rounds, raising a total of $65.40M. The latest funding stage is Series A.
Top alternatives and competitors to SEED Therapeutics include C4 Therapeutics, Inc., Cullgen Inc., Orum Therapeutics, Avilar Therapeutics, Vicinitas Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SEED Therapeutics and C4 Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SEED Therapeutics, https://bouncewatch.com/company/seed-therapeutics, updated 26 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout